Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
International Journal of Biological Macromolecules|October 18, 2025
Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinomaJia-Xin Shi, Michael Rose, Lara Heij, et al.Pathologie (Heidelberg, Germany)|November 26, 2025
POLQ and DNA-PK inhibition in muscle-invasive bladder cancer : Enhancing radiosensitivity with novel DNA damage response inhibitors to improve radiotherapy outcomesJulia Pannhausen, Ahmed A Chughtai, Michael K Melzer, et al.Current Oncology (Toronto, Ont.)|October 25, 2024
Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma-No Evidence for a Role in CarcinogenesisAugust Fiegl, Olaf Wendler, Johannes Giedl, et al.Genes|November 24, 2020
SWI/SNF Alterations in Squamous Bladder CancersFabian Achenbach, Michael Rose, Nadina Ortiz-Brüchle, et al.FEBS Open Bio|December 13, 2025
Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancerSophie Leypold, Janik Riese, Lancelot Seillier, et al.Genes|July 2, 2021
Molecular Characterization of Muellerian Tumors of the Urinary TractNadina Ortiz-Brüchle, Sophie Wucherpfennig, Michael Rose, et al.European Urology Focus|April 25, 2021
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?Chiara Maria Lavinia Loeffler, Nadina Ortiz Bruechle, Max Jung, et al.The Journal of Pathology|February 6, 2019
Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapyTimon Heide, Angela Maurer, Monika Eipel, et al.International Journal of Molecular Sciences|November 13, 2021
Evaluation of Therapeutic Targets in Histological Subtypes of Bladder CancerSophie Wucherpfennig, Michael Rose, Angela Maurer, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 1, 2010
Mutational activation of FGFR3 is not involved in the development of prostate cancerStella Koufou, Jens-Claudio Lunz, Albert Borchardt, et al.Pageof 10